MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acsptsci.6c00033

Медицинская библиотека · ACS pharmacology & translational science · 2026

Antiproliferation and Anti-invasion Activity of Binuclear Copper(II) Complex in BRAFi-Resistant Melanoma Cells.

de Moraes Junior Manoel Oliveira, Carvalho Larissa Anastácio da Costa, Mendonça Yasmin Catherine da Paz, da Silva Renaira Oliveira, Nunes Cleia Justino, Lima Keli, Machado-Neto João Agostinho, Rodrigues Tiago, Rebecca Vito, Bertolotto Corine, da Costa Ferreira Ana Maria, Maria-Engler Silvya Stuchi

СтатьяПеревод пока не подготовлен

Аннотация

Melanoma lethality is driven by high intratumoral heterogeneity, metastatic competence, and phenotypic plasticity, which foster rapid emergence of resistance to targeted therapies such as BRAF inhibitors (BRAFi, e.g. vemurafenib). Copper-(II) complexes have emerged as promising anticancer candidates, yet their activity against BRAFi-resistant melanoma remains poorly defined. Here, we show that the binuclear copper-(II) complex [Cu2(apyhist)2dpam]-(ClO4)4 (herein referred to as [Cu-(II)-L]) displays low-micromolar cytotoxicity and antiproliferative activity in parental and BRAFi-resistant melanoma models. Binuclear [Cu-(II)-L] suppresses melanoma migration and invasion and reduces tumor burden and dermal invasion in a reconstructed human skin melanoma model with limited toxicity to normal tissue. Mechanistically, [Cu2(apyhist)2dpam]-(ClO4)4 triggers a ROS-dependent stress response that is attenuated by N-acetylcysteine, leading to DNA damage, mitochondrial depolarization and caspase-independent cell death. Molecular profiling indicates engagement of cell cycle arrest and stress-adaptation programs, with signatures suggesting ferroptotic-associated, necroptotic and autophagy-related signaling, pointing to a redox-driven, diverse mechanism rather than a single dominant death pathway. Different modulation of key markers (PARP1, H2AX, MLKL, GPX4, LC3B-II, and p62) supports that its multitarget activity can bypass adaptive resistance mechanisms. Collectively, these findings support binuclear [Cu-(II)-L] as a candidate to target invasive and drug-resistant melanoma phenotypes.

Для цитирования: de Moraes Junior Manoel Oliveira, Carvalho Larissa Anastácio da Costa, Mendonça Yasmin Catherine da Paz, da Silva Renaira Oliveira, Nunes Cleia Justino, Lima Keli, Machado-Neto João Agostinho, Rodrigues Tiago, Rebecca Vito, Bertolotto Corine, da Costa Ferreira Ana Maria, Maria-Engler Silvya Stuchi. Antiproliferation and Anti-invasion Activity of Binuclear Copper(II) Complex in BRAFi-Resistant Melanoma Cells.. ACS pharmacology & translational science. 2026. DOI: 10.1021/acsptsci.6c00033.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.